Patents
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
07/2004
07/08/2004WO2004056727A2 Process of making chalcone derivatives
07/08/2004WO2004056347A2 Pharmaceutical compositions comprising insulin and legends of insulin hexamer
07/08/2004US20040133011 Useful for therapy of noninsulin-dependent diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome
07/08/2004US20040133008 Amide compounds
07/08/2004US20040132782 Aspartyl protease inhibitors
07/08/2004US20040132752 cyclic ureas and triazolones; treatment or prevention of excessive weight or obesity, and for treatment of Type II diabetes, arteriosclerosis, high blood pressure, depression, anxiety, anxiety neuroses, and schizophrenia.
07/08/2004US20040132619 Activity; crop compatibility; broad spectrum; cereals
07/08/2004US20040131958 Quenching efficiency; improving colorfastness; photooxidation and heat resistance; electrophoretic fluid displays; containing metal complexed ortho-hydroxyimino phenol functionality
07/08/2004CA2509405A1 Mek inhibiting oxa- and thia-diazol-2-yl phenylamine derivatives
07/07/2004EP1435352A2 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
07/07/2004EP1434772A1 Compounds and methods
07/07/2004EP1434585A1 Alkyne matrix metalloproteinase inhibitors
07/07/2004EP1071670B1 Novel diphenyl-substituted 5-ring-heterocycles, method for producing them and their use as medicaments
07/07/2004CN1156455C Preparation of 1-(2-fluorobenzene) substituted triazolinones
07/06/2004US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/06/2004US6759538 Substituted diphenyl heterocycles useful for treating HCV infection
07/06/2004US6759424 Imidazolidine derivatives, their preparation, their use, and pharmaceutical preparations comprising them
07/06/2004US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
07/06/2004US6758891 Surface treated cartbon black
07/01/2004WO2002100341A3 Compounds for the treatment of metabolic disorders
07/01/2004US20040127733 adrenergic blocking agents; for treatment of diabetes/obesity
07/01/2004US20040127513 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease
07/01/2004US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome
07/01/2004US20040127484 Novel bicyclic inhibitors of hormone sensitive lipase
06/2004
06/30/2004EP1432687A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
06/30/2004EP1037880B1 Retinoic acid mimetic anilides
06/30/2004CN1509300A Method for dimerisation ispohorone diisolyanate
06/30/2004CN1509285A Substituted aryl ketons
06/30/2004CN1155599C Tricyclic triazolobenzazepine derivatives, process for producing same, and antiallergic agent
06/29/2004US6756499 Reacting a bromo-functionalized benzotriazole ultraviolet radiation(uv) absorber
06/29/2004US6756216 Batch processing using nucleophilic compound
06/29/2004CA2329537C Method for making contact lenses having uv absorbing properties
06/24/2004WO2004052872A1 Haloalkene compounds, process for their production and pesticides containing them
06/24/2004WO2004052280A2 Anti-angiogenic compounds and their use in cancer treatment
06/24/2004WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/24/2004US20040122072 Thermally stable, anthraquinone colorants containing copolymerizable vinyl groups
06/24/2004US20040122071 Fluconazole, a compound selected from a group consisting of fatty acid, fatty alcohol, higher fatty acid ester and lower alcohol and a base; favorable absorption and delivery through the human skin; low skin stimulation; stability; spreading
06/24/2004US20040122050 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
06/24/2004US20040122004 such as (1R,2R)-N-[(1S)-2-amino-1-(4-fluorophenyl)-2-oxoethyl]-2-(4-{[{[ethyl(2-hydroxyethyl)amino]carbonyl}(4-fluorophenyl)amino]methyl}phenyl)cyclohexanecarboxamide; for prevention/treatment of cardiovascular disorders
06/24/2004US20040121995 such as trifluoromethanesulfonic acid, N-[4-(2,5-difluorophenyl)-4-(6-trifluoromethyl-pyridine-3-sulfonyl)-cyclohexyl]-amide; for treatment/prevention of Alzheimer's disease
06/24/2004US20040121989 Renal-selective biphenylalkyl 1H-substituted-1,2,4-triazole angiotensin II antagonists for treatment of hypertension
06/23/2004EP1430120A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
06/23/2004EP1430038A1 Ultraviolet light absorbers
06/23/2004EP1430032A2 Substituted amides for the treatment of neurological disorders
06/23/2004EP1429763A2 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER
06/23/2004CN1154650C Triazole-[4,5-d] pyrididines compound, its preparation, use and medical composition containing the same
06/23/2004CN1154489C Heterocyclic vinylethers against neurological disorders
06/17/2004WO2004050643A2 Non-nucleoside reverse transcriptase inhibitors
06/17/2004WO2004050642A1 1, 2, 3- triazole amide derivatives as cytokine inhibitors
06/17/2004WO2004035534A3 Novel compounds having a dopaminergic and/or serotoninergic activity
06/17/2004WO2004030611A3 Non-nucleoside reverse transcriptase inhibitors
06/17/2004WO2004018414A3 Antibacterial agents
06/17/2004US20040116491 Therapy for infections; autoimmune diseases; vision defects; asthma:eating disorders; cardiovascular disorders; liver disorders; antiallergens; antiinflammatory agents; antiulcer agnets
06/17/2004US20040116490 Compounds and methods
06/17/2004US20040116404 Sulphones which modulate the action of gamma secretase
06/16/2004EP1427699A1 Selective herbicides based on substituted arylsulfonylaminocarbonyl triazolinones and safeners
06/16/2004CN1505627A Cyclic amp-specific phosphodiesterase inhibitors
06/16/2004CN1505607A Peptide-deformylase inhibitors
06/16/2004CN1504514A Novel fluorinated dye stabilizers in fluorinated dielectric solvent
06/15/2004US6750233 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
06/10/2004WO2004048367A1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
06/10/2004WO2004048347A1 1,2,4-triazole derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
06/10/2004WO2004048346A1 Process for producing 1-substituted 4-carbamoyl-1,2,4-triazol-5-one derivative
06/10/2004WO2004048341A1 Novel heteroaryl derivative
06/10/2004WO2004047744A2 3-heterocyclic benzylamide derivatives as potassium channel openers
06/10/2004WO2003059265A3 Compositions and methods for treating heart failure
06/10/2004US20040110951 thiazolidinedione, oxadiazolidinedione, and triazolone compounds treating obesity, overweight condition, hyperlipidemia, glaucoma, cardiac arrhythmias, skin disorders, thyroid disease, hypothyroidism, thyroid cancer, diabetes, etc.
06/10/2004US20040110832 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
06/10/2004US20040110812 for production of coating; improved lightfastness/stability to ultraviolet radiation light
06/10/2004US20040110806 Dipeptide derivatives
06/10/2004US20040110753 Tyrosine derivatives
06/10/2004US20040110736 Cyclic derivatives as modulators of chemokine receptor activity
06/09/2004EP1141084B1 Novel polyether polyols based on triazole group containing compounds and a process for their production
06/09/2004CN1503795A Water-soluble triazole fungicide
06/09/2004CN1503784A 2-lminopyrrolidine derivatives
06/09/2004CN1502611A Novel DIAR compound
06/09/2004CN1152875C Oxyranyle-triazoline thiones and their use as microbicides
06/09/2004CN1152868C Substituted aryl ketones
06/08/2004US6747125 Gonadotropic release hormone (gnrh ) antagonists prevents ovulation of female mammalian eggs and/or the release of steroids by the gonads; used to treat steroid-dependent tumors; agonists can be used for control of reproduction
06/08/2004US6747041 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same
06/08/2004US6746989 Substituted benzoylpyrazoles as herbicides
06/08/2004CA2079692C Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
06/03/2004WO2004046121A1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
06/03/2004WO2004046120A2 Diaminotriazoles useful as inhibitors of protein kinases
06/03/2004WO2004027046A3 Methods of producing 4-amino-3-mercapto-triazoles
06/03/2004WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase
06/03/2004US20040106804 Process for preparing monohydrate and crystal modifications of fluconazole
06/03/2004US20040106803 e.g., 1-[4-[4-[[2-[(E)-2-[4-(Trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methoxy]phenyl]butyl]-1H-1,2,3-triazole; having a tyrosine kinase inhibitory action
06/03/2004US20040106664 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
06/03/2004US20040106626 amidine containing compounds which inhibit serine proteases
06/03/2004US20040106621 3-Heterocyclic benzylamide derivatives as potassium channel openers
06/03/2004US20040106614 Useful for the treatment of psychiatric and neurological disorders, as well as other diseases involving cannabinoid-CB1 neurotransmission
06/03/2004US20040106612 Selective inhibitor of cyclooxygenase-2 used as an antipyretic, an analgesic, and an antiinflammatory agent, with reduced side effects.
06/03/2004US20040106608 Novel imidazole compounds as transforming growth factor (TGF) inhibitors
06/03/2004CA2505789A1 Diaminotriazoles useful as inhibitors of protein kinases
06/02/2004EP1423107A2 Fatty alcohol drug conjugates
06/02/2004EP1087952B1 Benzazole compounds and their use
06/02/2004CN1501920A Substituted fluoralkoxyphenylsulfonylamino(thio)carbonyltriazolino(thi)ones
06/02/2004CN1152037C Organometallic complexes containing cationic heterocyclic carbenes
06/01/2004US6743939 Phenylheteroalkylamine derivatives
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 178